Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00688610
NCT00688610
Completed
Phase 2

Antibiotics in Patients With Acute Respiratory Tract Infections in Primary Care in Consideration of Procalcitonin as Additive Parameter

Hannover Medical School1 site in 1 country571 target enrollmentNovember 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRespiratory Tract Infection

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Respiratory Tract Infection
Sponsor
Hannover Medical School
Enrollment
571
Locations
1
Primary Endpoint
days with significant impairment due to acute respiratory tract infection
Status
Completed
Last Updated
17 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Antibiotics in patients with acute respiratory tract infections in primary care in consideration of procalcitonin as additive parameter.

The purpose of this study is to compare the ordinary manner of antibiotic- prescription with the prescription in consideration of procalcitonin-value in patients with acute respiratory tract infections.

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
June 2008
Last Updated
17 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •18 years or older
  • •Informed consent
  • •Respiratory tract infection based on the clinical judgement of the primary care physician

Exclusion Criteria

  • •Antibiotic pretreatment in previous 14 days
  • •Portal hypertension
  • •Major surgeries or multiple trauma which require hospitalization, in previous 4 weeks
  • •Autoimmune disease and systemic diseases (lupus erythematodes, wegener´s disease)
  • •Peritoneal dialysis
  • •Acute treated or recently operated medullary c-cell-carcinoma, SCLC, carcinoid
  • •Other inflammatory diseases (e.g. urinary tract infection, pyelonephritis, pancreatitis

Outcomes

Primary Outcomes

days with significant impairment due to acute respiratory tract infection

Time Frame: 14 to 28 days after infection

Secondary Outcomes

  • number of antibiotic prescriptions(28 days)

Study Sites (1)

Loading locations...

Similar Trials

Completed
N/A
ABC-trial.
NL-OMON2544560
Not Yet Recruiting
N/A
A Cluster Randomized Controlled Trial to Compare the Rate of Antibiotic InfusionAcute Upper Respiratory Tract InfectionBacterial Infections
NCT06620341Second Affiliated Hospital, School of Medicine, Zhejiang University11,900
Active, Not Recruiting
Phase 1
The ATHENIAN Study: A clinical trial investigating the efficacy and safety of discontinuing antibiotic therapy in adult patients infected with respiratory virusesPatients with viral respiratory tract infection (influenza virus, parainfluenza virus, respiratory syncytial virus or human metapneumovirus)Therapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2021-004248-11-NOAkershus University Hospital400
Active, Not Recruiting
Phase 1
Antibiotic THErapy iN vIral Airway iNfections (ATHENIAN): An open labelled randomized controlled pragmatic trial to evaluate the efficacy and safety of discontinuing antibiotic therapy in adult patients infected with respiratory virusesViral respiratory tract infectionTherapeutic area: Diseases [C] - Virus Diseases [C02]
CTIS2023-509286-20-00Akershus University Hospital400
Not Yet Recruiting
N/A
Reducing Antibiotic Prescribing in Family PracticeAcute Respiratory Tract Infection
NCT03674775Seattle Children's Hospital180